The mechanism of action of glatiramer acetate treatment in multiple sclerosis

Conference proceeding

Peer reviewed

Michael K RACKE, Amy E LOVETT-RACKE and Nitin J KARANDIKAR

Neurology, Vol.74(1), pp.S25-S30

Multiple Sclerosis Disease-Modifying Therapies: Mechanisms of Action and Practical Implications

2010

DOI: 10.1212/WNL.0b013e3181c97e39

PMID: 20038760

View Online

Neurology

Biological and medical sciences

Multiple sclerosis and variants. Guillain barré syndrome and other inflammatory polyneuropathies. Leukoencephalitis

Medical sciences

Title: Subtitle: The mechanism of action of glatiramer acetate treatment in multiple sclerosis
Creators: Michael K RACKE - Departments of Neurology and Molecular Virology, Immunology, and Medical Genetics, The Ohio University Medical Center, Columbus, OH, United States
Amy E LOVETT-RACKE - Departments of Neurology and Molecular Virology, Immunology, and Medical Genetics, The Ohio University Medical Center, Columbus, OH, United States
Nitin J KARANDIKAR - Departments of Pathology and Neurology, The University of Texas Southwestern, Dallas, TX, United States
Resource Type: Conference proceeding
Publication Details: Neurology, Vol.74(1), pp.S25-S30
Conference: Multiple Sclerosis Disease-Modifying Therapies: Mechanisms of Action and Practical Implications
Publisher: Lippincott Williams & Wilkins; Hagerstown, MD
DOI: 10.1212/WNL.0b013e3181c97e39
PMID: 20038760
ISSN: 0028-3878
eISSN: 1526-632X
Language: English
Date published: 2010
Academic Unit: Pathology
Record Identifier: 9984046926802771

9 Record Views